scholarly article | Q13442814 |
P819 | ADS bibcode | 2011PLoSO...627842L |
P356 | DOI | 10.1371/JOURNAL.PONE.0027842 |
P932 | PMC publication ID | 3219696 |
P698 | PubMed publication ID | 22114708 |
P5875 | ResearchGate publication ID | 51828095 |
P50 | author | Søren Molin | Q26883279 |
Adela M Luján | Q79447992 | ||
María D Maciá | Q79793431 | ||
P2093 | author name string | Liang Yang | |
Antonio Oliver | |||
Andrea M Smania | |||
P2860 | cites work | sigmaB regulates IS256-mediated Staphylococcus aureus biofilm phenotypic variation | Q24680463 |
Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa | Q24683834 | ||
The genomics and proteomics of biofilm formation | Q24796049 | ||
DNA mismatch repair in eukaryotes and bacteria | Q28291067 | ||
Pseudomonas aeruginosa biofilms in cystic fibrosis | Q28299966 | ||
Nucleotides and heteroduplex DNA preserve the active conformation of Pseudomonas aeruginosa MutS by preventing protein oligomerization | Q28366275 | ||
The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants | Q28492790 | ||
Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms | Q28493090 | ||
Quantification of biofilm structures by the novel computer program comstat | Q28547921 | ||
Adaptive divergence in experimental populations of Pseudomonas fluorescens. I. Genetic and phenotypic bases of wrinkly spreader fitness | Q28768990 | ||
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia | Q29615286 | ||
Biofilms as complex differentiated communities | Q29615299 | ||
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients | Q29615301 | ||
Mismatch repair in replication fidelity, genetic recombination, and cancer biology | Q29616483 | ||
Development and dynamics of Pseudomonas sp. biofilms | Q30659180 | ||
Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants | Q30944663 | ||
Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa. | Q30974317 | ||
Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment. | Q31029779 | ||
Phenotypic diversification and adaptation of Serratia marcescens MG1 biofilm-derived morphotypes | Q33261957 | ||
Physiological heterogeneity in biofilms | Q33319084 | ||
Role of mutation in Pseudomonas aeruginosa biofilm development. | Q33482815 | ||
Spatial physiological heterogeneity in Pseudomonas aeruginosa biofilm is determined by oxygen availability | Q33718373 | ||
Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. | Q47946251 | ||
The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants | Q50192890 | ||
Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms. | Q51479991 | ||
Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. | Q52575837 | ||
MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa. | Q52579021 | ||
Role of mutator alleles in adaptive evolution. | Q54564129 | ||
Adaptive radiation in a heterogeneous environment | Q56038387 | ||
Role of chronic Pseudomonas aeruginosa infection in the development of bronchiectasis | Q67574773 | ||
Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis | Q68229087 | ||
Genetic recombination in Pseudomonas aeruginosa | Q73881599 | ||
Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease | Q79805323 | ||
The effect of elevated mutation rates on the evolution of cooperation and virulence of Pseudomonas aeruginosa | Q84417552 | ||
Molecular tools for study of biofilm physiology | Q33766161 | ||
Wider access to genotypic space facilitates loss of cooperation in a bacterial mutator | Q33833686 | ||
Amplification of mutator cells in a population as a result of horizontal transfer | Q33996324 | ||
Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections | Q34117477 | ||
The rise and fall of mutator bacteria. | Q34392588 | ||
Evolution of high mutation rates in experimental populations of E. coli | Q34429727 | ||
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis | Q34588476 | ||
Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections | Q34693974 | ||
Evolutionary dynamics of bacteria in a human host environment | Q34937408 | ||
Proliferation of mutators in A cell population | Q35618973 | ||
Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms | Q35759418 | ||
Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa | Q35772673 | ||
Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. | Q35879111 | ||
Characterization of a Pseudomonas putida rough variant evolved in a mixed-species biofilm with Acinetobacter sp. strain C6. | Q35879451 | ||
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation | Q36295397 | ||
Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation | Q36456326 | ||
Endogenous oxidative stress produces diversity and adaptability in biofilm communities | Q36858633 | ||
Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. | Q37074619 | ||
P. aeruginosa Biofilms in CF Infection | Q37176167 | ||
Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung | Q37191781 | ||
Self-generated diversity produces "insurance effects" in biofilm communities | Q37621081 | ||
Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities | Q39502437 | ||
Cell death in Pseudomonas aeruginosa biofilm development. | Q39791484 | ||
Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients | Q39955018 | ||
Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection | Q39997040 | ||
Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa | Q40557981 | ||
Highly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q40658282 | ||
Impact of mutS inactivation on foreign DNA acquisition by natural transformation in Pseudomonas stutzeri | Q40731504 | ||
Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix | Q40993746 | ||
Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation | Q41366386 | ||
Generation of virulence factor variants in Staphylococcus aureus biofilms. | Q41776223 | ||
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation | Q41825397 | ||
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections | Q41974061 | ||
Characterization of colony morphology variants isolated from Pseudomonas aeruginosa biofilms | Q42105451 | ||
Heterogeneity of biofilms formed by nonmucoid Pseudomonas aeruginosa isolates from patients with cystic fibrosis | Q42561285 | ||
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation | Q42674600 | ||
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants | Q43153453 | ||
Mismatch repair and the regulation of phase variation in Neisseria meningitidis | Q43612705 | ||
Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. | Q46002328 | ||
Increased mutability of Pseudomonas aeruginosa in biofilms | Q46767850 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Pseudomonas aeruginosa | Q31856 |
biofilm | Q467410 | ||
DNA mismatch repair | Q2984243 | ||
P304 | page(s) | e27842 | |
P577 | publication date | 2011-11-17 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators | |
P478 | volume | 6 |
Q92330383 | An in vitro collagen perfusion wound biofilm model; with applications for antimicrobial studies and microbial metabolomics |
Q38166240 | Bacterial signaling ecology and potential applications during aquatic biofilm construction. |
Q59132158 | Causes and Consequences of a Variant Strain of With Reduced Competition |
Q34393008 | Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli. |
Q34948367 | Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. |
Q35350270 | Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections. |
Q47343132 | Combination of 247 genome-wide association studies reveals high cancer risk as a result of evolutionary adaptation |
Q46590167 | Effect of interspecific competition on trait variation in Phaeobacter inhibens biofilms |
Q35996425 | Establishment of a multi-species biofilm model and metatranscriptomic analysis of biofilm and planktonic cell communities. |
Q64448641 | Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin |
Q37248273 | Evolution of Ecological Diversity in Biofilms of Pseudomonas aeruginosa by Altered Cyclic Diguanylate Signaling |
Q26768691 | Experimental evolution in biofilm populations. |
Q38273318 | Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. |
Q35939649 | Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections. |
Q41062024 | Spatial Organization Plasticity as an Adaptive Driver of Surface Microbial Communities |
Q26747423 | Sub-Optimal Treatment of Bacterial Biofilms |
Q34860393 | Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium |
Q92707838 | Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model |
Q36639773 | Targeting bacterial integration host factor to disrupt biofilms associated with cystic fibrosis |
Q35885995 | The properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosa |
Q64068057 | Tolerance and Resistance of Pseudomonas aeruginosa Biofilms to Antimicrobial Agents—How P. aeruginosa Can Escape Antibiotics |
Search more.